SIR BILL ENGLISH APPOINTED AS PATRON OF EPILEPSY NEW ZEALAND

MEDIA RELEASE

29 November 2018

SIR BILL ENGLISH APPOINTED AS PATRON OF EPILEPSY NEW ZEALAND

Epilepsy New Zealand is proud to announce that Sir Bill English has graciously agreed to become patron of the national organisation.

Chair of Epilepsy New Zealand, Dr Peter Bergin says: “We are grateful to welcome Sir Bill English as our patron. To have such a skilled person supporting our cause - which is to improve the quality of life of people and their families living with epilepsy - is invaluable.”

Sir Bill has agreed to be patron of Epilepsy New Zealand as the largest charity in New Zealand tackling the discrimination and stigma that faces the 48,000 people living with epilepsy throughout the country, and it provides day-to-day practical support for them.

Its National office is in Hamilton from where it operates 12 offices throughout New Zealand, employing 20 staff that deliver critical services to people and families living with epilepsy.

Sir Bill English says: "I am pleased to become patron of this important organisation that works to help the many New Zealanders who live with epilepsy. This is an illness that is often misunderstood. It is vital to improve understanding throughout the community and increase the support of Epilepsy New Zealand to ensure the significant work that it does up and down the country can continue."

Services provided by ENZ include providing information to people with epilepsy and their families; direct support and advocacy; education and training services for health professionals, schools and rest homes.

Broader public awareness campaigns about epilepsy are held each year. The two most notable include ‘Purple Day’ on March 26 and ‘November Awareness’ month.

CEO of Epilepsy New Zealand, Graeme Ambler says: “Every day six people will be diagnosed with epilepsy and we welcome Sir Bill's support as we strive to end the archaic stigma surrounding the condition. 

“As a registered charity, Epilepsy New Zealand is reliant upon community support to survive.

“We have a contract with all DHBs in New Zealand that provides revenue of around $400,000 per year. The remaining $1.2M needed to maintain our countrywide services comes from grants, donations and membership support.

“We want to find a cure for epilepsy, to find drugs with fewer side effects and to understand living with epilepsy better,” says Graeme Ambler.

“We invite businesses to become registered as ‘Best Practice Employers’ and to publicly display their support for people living with epilepsy. We encourage schools to receive presentations to students to increase awareness of the condition, especially seizure first aid.”

Find out more about epilepsy. Visit www.epilepsy.org.nz or contact Epilepsy New Zealand on (07) 834 3556.  For support call our freephone 0800 EPILEPSY.

Contact:

Graeme Ambler 

M: 022 0800 105

CEO/Secretary

EPILEPSY ASSOCIATION OF NEW ZEALAND INC.

 

Prev   Next 

Latest Updates

  • PHARMAC to widen access to the exceptional circumstances process
    21 November 2019

    Patients taking lamotrigine who have concerns about the change can talk to their doctor about remaining on the current brand as PHARMAC has widened the criteria for lamotrigine exceptional circumstances.

  • PHARMAC Decision welcomed by Epilepsy New Zealand
    21 November 2019

    Epilepsy New Zealand President Dr Peter Bergin welcomes the news that Pharmac are now allowing people who have been stable on their previous brands of lamotrigine to continue taking their original brand.

  • PHARMAC waives fees to visit doctor
    21 November 2019

    If you have visited your doctor recently to seek advice on the brand changes for lamotrigine, your GP can waive the co-payment you would normally pay.

  • Tell us your experience of changing from Lamictal to Logem
    2 October 2019

    From 01 Oct 2019, Pharmac only funds the generic brand of Lamotrigine, called Logem. They no longer fund the Lamictal and Arrow brands. Tell us how it's going for you.

  • BPAC issues new guidelines for Lamotrigine
    26 September 2019

    BPAC issues new guidelines for Lamotrigine.

  • Petition against Pharmac's drug changes
    29 August 2019

    A petition is underway calling on Pharmac to reverse its decision on Lamotrigine.

  • Epilepsy NZ Position Statement - Lamotrigine
    28 August 2019

    We opposed this change from Lamictal to Logem from the start, and staff have advocated on behalf of people with epilepsy in discussions with Pharmac.

  • Introducing Ashleigh
    19 February 2018

    Ashleigh is a great young woman from Canterbury, this story is written about her epilepsy by her mother, she is heading to Cleveland for epilepsy treatment.

  • Don't Give Up by Adele Hauwai
    4 December 2017

    Adele Hauwai has shared her Living With Epilepsy story as part of the Epilepsy NZ Tell Us About It Competition. People were asked to send in their stories about epilepsy, the challenges they faced and the lessons they have learned that they would like to share with the world.

  • New ILAE Seizure Classification
    10 March 2017

    The ILAE announces the publication in Epilepsia of two new landmark classification documents, one of seizure types and one of the epilepsies.

Show Your Support

Shop Online

Epilepsy NZ has an online shop!

Or

Donate Today